Welcome to the latest issue of our European Life Sciences Review, produced by our life sciences lawyers in London, Brussels, Frankfurt, Moscow, and Paris and covering some of the most critical developments in the pharmaceutical and medical technology sectors in the last month. If you have questions on any of these topics, please contact Paul Ranson.
In this issue, we cover updates relating to:
Read the seventh issue of the
European Life Sciences Review >>